enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.
Over the last 12 months, insiders at enVVeno Medical Corporation have bought $0 and sold $51,837 worth of enVVeno Medical Corporation stock.
On average, over the past 5 years, insiders at enVVeno Medical Corporation have bought $60,941 and sold $279,625 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 7,751 shares for transaction amount of $47,591 was made by Duhay Francis () on 2022‑08‑16.
2024-03-13 | Sale | Alavi Hamed | Chief Technology Officer | 8,334 0.0626% | $6.22 | $51,837 | -21.01% | |
2022-08-16 | Duhay Francis | 7,751 0.0731% | $6.14 | $47,591 | -11.21% | |||
2022-06-30 | Shrivastava Sanjay | 1,000 0.0091% | $3.85 | $3,850 | +39.42% | |||
2022-06-27 | BERMAN ROBERT ANDREW | Chief Executive Officer | 2,500 0.0221% | $3.80 | $9,500 | +37.42% | ||
2020-08-21 | Sale | Biodyne Holding, S.A. | 75,000 0.1713% | $0.38 | $28,500 | -35.13% | ||
2020-08-20 | Sale | Biodyne Holding, S.A. | 75,000 0.1995% | $0.27 | $20,250 | +6.30% | ||
2020-08-19 | Sale | Biodyne Holding, S.A. | 50,000 0.138% | $0.30 | $15,000 | -1.26% | ||
2020-08-18 | Sale | Biodyne Holding, S.A. | 50,000 0.1493% | $0.34 | $17,000 | -5.17% | ||
2020-08-14 | Sale | Biodyne Holding, S.A. | 50,000 0.1353% | $0.31 | $15,500 | -5.05% | ||
2020-08-03 | Sale | Biodyne Holding, S.A. | 70,000 0.1916% | $0.32 | $22,400 | -4.48% | ||
2020-07-31 | Sale | Biodyne Holding, S.A. | 5,000 0.0143% | $0.34 | $1,700 | -5.58% | ||
2020-07-30 | Sale | Biodyne Holding, S.A. | 25,000 0.0691% | $0.32 | $8,000 | -2.40% | ||
2020-07-21 | Sale | Biodyne Holding, S.A. | 50,000 0.1415% | $0.45 | $22,500 | -27.93% | ||
2020-07-20 | Sale | Biodyne Holding, S.A. | 150,000 0.4083% | $0.43 | $64,500 | -27.32% | ||
2020-07-17 | Sale | Biodyne Holding, S.A. | 50,000 0.1317% | $0.38 | $19,000 | -20.10% | ||
2020-07-16 | Sale | Biodyne Holding, S.A. | 50,000 0.1413% | $0.38 | $19,000 | -14.14% | ||
2020-07-06 | Sale | Biodyne Holding, S.A. | 6,450 0.0173% | $0.39 | $2,516 | -19.58% | ||
2020-07-02 | Sale | Biodyne Holding, S.A. | 57,000 0.1505% | $0.40 | $22,800 | -22.72% | ||
2020-07-01 | Sale | Biodyne Holding, S.A. | 45,000 0.1213% | $0.38 | $17,100 | -16.92% | ||
2020-06-29 | Sale | Biodyne Holding, S.A. | 68,094 0.3173% | $0.39 | $26,557 | -16.77% |
Alavi Hamed | Chief Technology Officer | 0 0% | $5.15 | 0 | 1 | |
Biodyne Holding, S.A. | 1405433 10.554% | $5.15 | 0 | 27 | ||
BERMAN ROBERT ANDREW | Chief Executive Officer | 210236 1.5788% | $5.15 | 1 | 0 | +37.42% |
Duhay Francis | 20911 0.157% | $5.15 | 1 | 0 | <0.0001% | |
Shrivastava Sanjay | 3888 0.0292% | $5.15 | 1 | 0 | +39.42% |
Kingdon Capital Management | $3.56M | 4.91 | 653,870 | +5.6% | +$188,713.61 | 0.47 | |
Perceptive Advisors | $3.39M | 4.68 | 623,315 | 0% | +$0 | <0.01 | |
The Vanguard Group | $3.12M | 4.31 | 573,955 | +70.61% | +$1.29M | <0.0001 | |
Nantahala Capital Management Llc | $2.7M | 3.72 | 495,736 | -29.81% | -$1.15M | 0.28 | |
Ubs Oconnor Llc | $1.23M | 1.7 | 226,308 | -4.23% | -$54,400.02 | 0.11 | |
Velan Capital | $936,958.00 | 1.29 | 172,235 | 0% | +$0 | 0.51 | |
Geode Capital Management | $747,882.00 | 1.03 | 137,456 | +12.56% | +$83,463.14 | <0.0001 | |
Morgan Stanley | $530,672.00 | 0.73 | 97,550 | +61.12% | +$201,307.20 | <0.0001 | |
Citadel Advisors LLC | $247,852.00 | 0.34 | 45,561 | +14.12% | +$30,670.74 | <0.0001 | |
Ria Advisory Group Llc | $237,543.00 | 0.33 | 43,666 | New | +$237,543.00 | 0.1 | |
Marshall Wace | $218,253.00 | 0.3 | 40,120 | +162.22% | +$135,020.92 | <0.0001 | |
BlackRock | $203,951.00 | 0.28 | 37,491 | -1.7% | -$3,536.00 | <0.0001 | |
Northern Trust | $191,173.00 | 0.26 | 35,142 | -6.35% | -$12,969.00 | <0.0001 | |
Janney Montgomery Scott LLC | $186,000.00 | 0.26 | 34,140 | New | +$186,000.00 | <0.01 | |
Laird Norton Trust Company Llc | $179,520.00 | 0.25 | 33,000 | +230% | +$125,120.00 | 0.02 | |
Jane Street Capital | $137,703.00 | 0.19 | 25,313 | New | +$137,703.00 | <0.0001 | |
State Street | $133,824.00 | 0.19 | 24,600 | -7.52% | -$10,880.00 | <0.0001 | |
Fermata Advisors Llc | $126,197.00 | 0.17 | 23,198 | +42.1% | +$37,389.08 | 0.03 | |
Squarepoint Ops LLC | $121,867.00 | 0.17 | 22,402 | New | +$121,867.00 | <0.0001 | |
Quadrature Capital Ltd | $103,230.00 | 0.14 | 18,872 | New | +$103,230.00 | <0.01 | |
Dimensional Fund Advisors | $89,276.00 | 0.12 | 16,411 | -10.35% | -$10,303.38 | <0.0001 | |
Tamar Securities | $76,106.00 | 0.11 | 13,990 | 0% | +$0 | 0.01 | |
Hrt Financial Llc | $75,000.00 | 0.1 | 13,873 | New | +$75,000.00 | <0.0001 | |
Advisor Group Holdings Inc | $61,744.00 | 0.09 | 11,350 | 0% | +$0 | <0.0001 | |
Acadian Asset Management | $37,000.00 | 0.05 | 6,825 | New | +$37,000.00 | <0.0001 | |
UBS | $30,235.00 | 0.04 | 5,558 | +555,700% | +$30,229.56 | <0.0001 | |
Westside Investment Management Inc | $20,400.00 | 0.03 | 3,750 | New | +$20,400.00 | 0.01 | |
Tower Research Capital | $18,970.00 | 0.03 | 3,487 | +22.48% | +$3,481.73 | <0.0001 | |
Wells Fargo | $11,397.00 | 0.02 | 2,095 | +0.1% | +$10.88 | <0.0001 | |
Cibc Private Wealth Group Llc | $4,532.00 | 0.01 | 860 | New | +$4,532.00 | <0.0001 | |
Royal Bank of Canada | $0 | <0.01 | 11 | -89% | -$0 | <0.0001 |